Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Kristine, McKinney"'
Autor:
Eric Yi-Chun Huang, Clayton Small, William Walker, Tal Zaks, Jared Iacovelli, Kristine Mckinney, Kristen Hopson, Sze-Wah Tse, Mychael Nguyen
Publikováno v:
Molecular Therapy. 29:2227-2238
mRNA vaccines induce potent immune responses in preclinical models and clinical studies. Adjuvants are used to stimulate specific components of the immune system to increase immunogenicity of vaccines. We utilized a constitutively active mutation (V1
Autor:
Olivier J Becherel, Abrey J Yeo, Alissa Stellati, Evelyn Y H Heng, John Luff, Amila M Suraweera, Rick Woods, Jean Fleming, Dianne Carrie, Kristine McKinney, Xiaoling Xu, Chuxia Deng, Martin F Lavin
Publikováno v:
PLoS Genetics, Vol 9, Iss 4, p e1003435 (2013)
Senataxin, mutated in the human genetic disorder ataxia with oculomotor apraxia type 2 (AOA2), plays an important role in maintaining genome integrity by coordination of transcription, DNA replication, and the DNA damage response. We demonstrate that
Externí odkaz:
https://doaj.org/article/2ecf92590ec44c4b86789df144fc8688
Autor:
David M. Mauger, Samuel J. Farlow, Eric Yi-Chun Huang, Josh Frederick, Kristin E. Burke, Jeffrey Pimentel, Tirtha Chakraborty, Melissa J. Moore, Caroline Köhrer, Summar Siddiqui, Kristine Mckinney, Ruchi Jain, Elizaveta A. Andrianova, Kahlin Cheung-Ong
Publikováno v:
Nucleic Acid Therapeutics. 28:285-296
The advent of therapeutic mRNAs significantly increases the possibilities of protein-based biologics beyond those that can be synthesized by recombinant technologies (eg, monoclonal antibodies, extracellular enzymes, and cytokines). In addition to th
Autor:
Sze-Wah, Tse, Kristine, McKinney, William, Walker, Mychael, Nguyen, Jared, Iacovelli, Clayton, Small, Kristen, Hopson, Tal, Zaks, Eric, Huang
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy. 29(7)
mRNA vaccines induce potent immune responses in preclinical models and clinical studies. Adjuvants are used to stimulate specific components of the immune system to increase immunogenicity of vaccines. We utilized a constitutively active mutation (V1
Publikováno v:
International Communication Gazette. 71:671-692
This study reports results from a content analysis of comparative advertising studies published in 11 major journals between 1975 and 2005. In the context of sociology of knowledge, the objective was to determine how we come to know what we know abou
Publikováno v:
Journal of Biological Chemistry. 279:5802-5810
The cyclin-dependent kinase inhibitor p21, a major transcriptional target of the tumor suppressor p53, plays a critical role in cell cycle arrest in G1 and G2 after DNA damage. It was previously shown that in some human cell lines when S phase is arr
Autor:
Jinwoo Ahn, Carol Prives, Masha V. Poyurovsky, Rachel Beckerman, Nicole Baptiste, Melissa Mattia, Jianmin Zhou, Andrew Zupnick, Christine Cain, Kristine McKinney, Vanesa Gottifredi
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Scopus-Elsevier
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Scopus-Elsevier
Both sequence-specific DNA binding and exonuclease activities have been mapped to the central conserved core domain of p53. To gain more information about these two activities a series of mutants were generated that changed core domain histidine resi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06e741908264c2bb127a851ae26516e5
http://www.tandfonline.com/doi/abs/10.4161/cc.8.10.8548
http://www.tandfonline.com/doi/abs/10.4161/cc.8.10.8548
Autor:
Kristine McKinney, Alan R. Fersht, Michael P. Sheetz, Rachel Beckerman, Andrew Zupnick, Orit Karni-Schmidt, Philippe Bouvet, Assaf Friedler, Melissa Mattia, Carol Prives
Publikováno v:
Oncogene
Oncogene, Nature Publishing Group, 2007, 26, pp.3878-3891. ⟨10.1038/sj.onc.1210162⟩
Oncogene, 2007, 26, pp.3878-3891. ⟨10.1038/sj.onc.1210162⟩
Oncogene, Nature Publishing Group, 2007, 26, pp.3878-3891. ⟨10.1038/sj.onc.1210162⟩
Oncogene, 2007, 26, pp.3878-3891. ⟨10.1038/sj.onc.1210162⟩
The p53 tumor suppressor is a nucleocytoplasmic shuttling protein that is found predominantly in the nucleus of cells. In addition to mutation, abnormal p53 cellular localization is one of the mechanisms that inactivate p53 function. To further under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e7a4fabe5f83eabc959752d9b6fd7cf
https://hal.archives-ouvertes.fr/hal-00378604
https://hal.archives-ouvertes.fr/hal-00378604
We have previously reported that when DNA replication is blocked in some human cell lines, p53 is impaired in its ability to induce a subset of its key target genes, including p21(WAF1/CIP1). Here, we investigated the reason for this impairment by co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::264069d1befd744e965e97fbb6c32d8a
http://mcb.asm.org/content/27/4/1309
http://mcb.asm.org/content/27/4/1309
Autor:
Kristine McKinney, Neil Justin, Steven J. Gamblin, Paul Tempst, Julia K. Kurash, Gleb S. Ivanov, Sergei Chuikov, Danny Reinberg, Carol Prives, Nickolai A. Barlev, Bing Xiao, Jonathan R. Wilson
Publikováno v:
Nature. 432(7015)
p53 is a tumour suppressor that regulates the cellular response to genotoxic stresses. p53 is a short-lived protein and its activity is regulated mostly by stabilization via different post-translational modifications. Here we report a novel mechanism